Trial Profile
Lamotrigine as an Antidepressant Augmentation Agent in Treatment Refractory Unipolar Depression.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 Jul 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary) ; Paroxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- 22 May 2009 New trial record